Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients:: The Losartan Intervention For Endpoint Reduction (LIFE) study

被引:33
|
作者
Oikarinen, L
Nieminen, MS
Toivonen, L
Viitasalo, M
Wachtell, K
Papademetriou, V
Jern, S
Dahlöf, B
Devereux, RB
Okin, PM
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Cardiol, FIN-00290 Helsinki, Finland
[2] Copenhagen Cty Univ Hosp, Glostrup, Denmark
[3] Vet Adm Hosp, Washington, DC USA
[4] Sahlgrens Univ Hosp, Gothenburg, Sweden
[5] Cornell Univ, Weill Med Coll, Dept Med, Div Cardiol, New York, NY USA
关键词
D O I
10.1016/S0002-8703(02)94785-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In hypertensive patients, both echocardiographic and electrocardiographic left ventricular hypertrophy (LVH) increase the risk of sudden death, possibly in part because of LVH-induced proarrhythmic repolarization changes. Experimentally, regression of LVH normalizes ventricular electrophysiology. Methods To assess the relation of regression of LVH to changes in electrocardiographic measures of ventricular repolarization, we studied 317 hypertensive (61.2% men, mean age 65 +/- 7 years) participants in the Losartan Intervention For Endpoint Reduction (LIFE) study with electrocardiographic evidence of LVH, at study baseline, and after 1 year of blood pressure-lowering treatment with losartan or atenolol and hydrochlorothiatzide as the first adjunct therapy if needed to reach target blood pressure of 140/90 mm Hg. As indexes of LVH, we used echocardiographically determined LV mass as well as the Sokolow-Lyon and Cornell voltages from the electrocardiogram. QT interval duration and QT dispersion from the 12-lead electrocardiogram were used as ventricular repolarization measures. Results By using tertiles of IV mass change and adjusting for the difference in treatment (losartan or atenolol), shortening of the rate-adjusted QT intervals as well as reduction in QT(apex) dispersion were observed in the tertile showing the greatest decrease in LV mass but not in the tertile without substantial changes in IV mass despite a significant reduction in blood pressure. Similar results were obtained with the use of Sokolow-Lyon and Cornell voltage change tertiles. Conclusions In hypertensive patients with electrocardiographic evidence of LVH, regression of echocardiographically determined IV mass and electrocardiographic indexes of LVH may partially reverse the LVH-induced proarrhythmic repolarization changes. This may have a beneficial impact on the increased incidence of sudden death in these patients.
引用
收藏
页码:919 / 925
页数:7
相关论文
共 50 条
  • [1] Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients.: The LIFE study.
    Oikarinen, L
    Nieminen, MS
    Viitasalo, M
    Toivonen, L
    Wachtell, K
    Papademetriou, V
    Jern, S
    Dahlöf, B
    Devereux, RB
    Okin, PM
    JOURNAL OF HYPERTENSION, 2001, 19 (10) : 1883 - 1891
  • [2] QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy -: The Losartan Intervention for Endpoint Reduction in Hypertension study
    Oikarinen, L
    Nieminen, MS
    Viitasalo, M
    Toivonen, L
    Jern, S
    Dahlöf, B
    Devereux, RB
    Okin, PM
    HYPERTENSION, 2004, 43 (05) : 1029 - 1034
  • [3] Relation of QT interval to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients: The LIFE study
    Oikarinen, L
    Nieminen, MS
    Viitasalo, M
    Toivonen, L
    Wachtell, K
    Papademetriou, V
    Jern, S
    Dahlof, B
    Liu, JE
    Okin, PM
    CIRCULATION, 2000, 102 (18) : 696 - 696
  • [4] Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients -: The Losartan Intervention for Endpoint reduction (LIFE) in hypertension study
    Okin, PM
    Devereux, RB
    Jern, S
    Kjeldsen, SE
    Julius, S
    Dahlöf, B
    HYPERTENSION, 2000, 36 (05) : 766 - 773
  • [5] Relation of QT Interval to Echocardiographic Left Ventricular Hypertrophy and Geometric Pattern in Hypertensive Patients
    Anshari, Afif
    Wijayanto, Mohammad A.
    Haikal
    Soesanto, Amiliana M.
    Sukamiartadana, I. N.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0F) : F65 - F65
  • [6] Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients -: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study
    Okin, PM
    Jern, S
    Devereux, RB
    Kjeldsen, SE
    Dahlöf, B
    HYPERTENSION, 2000, 35 (01) : 13 - 18
  • [7] Regression of electrocardiographic left ventricular hypertrophy by Losartan versus atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
    Okin, PM
    Devereux, RB
    Jern, S
    Kjeldsen, SE
    Julius, S
    Nieminen, MS
    Snapinn, S
    Harris, KE
    Aurup, P
    Edelman, JM
    Dahlöf, B
    CIRCULATION, 2003, 108 (06) : 684 - 690
  • [8] QT interval variables as predictors of outcome in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study
    Okarinen, L
    Viitasalo, M
    Toivonen, L
    Jern, S
    Nieminen, MS
    Okin, PM
    CIRCULATION, 2002, 106 (19) : 544 - 544
  • [9] Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial
    Devereux, RB
    Dahlöf, B
    Gerdts, E
    Boman, K
    Nieminen, MS
    Papademetriou, V
    Rokkedal, J
    Harris, KE
    Edelman, JM
    Wachtell, K
    CIRCULATION, 2004, 110 (11) : 1456 - 1462
  • [10] Left ventricular hypertrophy and QT dispersion in hypertensive patients
    Sisó, A
    Dalfó, A
    Pou, M
    JOURNAL OF HYPERTENSION, 2000, 18 : S44 - S44